Organization | Tate & Lyle

Tate & Lyle Report issue

For profit

Founded: Liverpool United Kingdom (1921)

Status: No NME R&D (1921)

Organization Overview

First Clinical Trial

2008

NCT00958399

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Tate and Lyle Ingredients Americas LLC | Tate and Lyle Ingredients France | Tate & Lyle

Active Ingredients

Drugs in Other Trials (12)

corn (8 trials)

d-allulose (1 trial)

glucose polymer fiber (1 trial)

inulin (1 trial)

maltodextrin (2 trials)

monk fruit (1 trial)

resistant starch (1 trial)

soluble fiber (2 trials)

stevia (1 trial)

sucralose (1 trial)

sucrose (1 trial)

water (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 10
# of Trial APIs: 12